Cargando…

Advances in Nanogels for Topical Drug Delivery in Ocular Diseases

Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yongkang, Tao, Qing, Xie, Jing, Lu, Lili, Xie, Xiuli, Zhang, Yang, Jin, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137933/
https://www.ncbi.nlm.nih.gov/pubmed/37102904
http://dx.doi.org/10.3390/gels9040292
_version_ 1785032586155786240
author Wu, Yongkang
Tao, Qing
Xie, Jing
Lu, Lili
Xie, Xiuli
Zhang, Yang
Jin, Yong
author_facet Wu, Yongkang
Tao, Qing
Xie, Jing
Lu, Lili
Xie, Xiuli
Zhang, Yang
Jin, Yong
author_sort Wu, Yongkang
collection PubMed
description Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulting in a short retention time and low drug bioavailability, which is a significant challenge for physicians, patients, and pharmacists. Nanogels, however, have the ability to encapsulate drugs within three-dimensional crosslinked polymeric networks and, through specific structural designs and distinct methods of preparation, achieve the controlled and sustained delivery of loaded drugs, increasing patient compliance and therapeutic efficiency. In addition, nanogels have higher drug-loading capacity and biocompatibility than other nanocarriers. In this review, the main focus is on the applications of nanogels for ocular diseases, whose preparations and stimuli-responsive behaviors are briefly described. The current comprehension of topical drug delivery will be improved by focusing on the advances of nanogels in typical ocular diseases, including glaucoma, cataracts, dry eye syndrome, and bacterial keratitis, as well as related drug-loaded contact lenses and natural active substances.
format Online
Article
Text
id pubmed-10137933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101379332023-04-28 Advances in Nanogels for Topical Drug Delivery in Ocular Diseases Wu, Yongkang Tao, Qing Xie, Jing Lu, Lili Xie, Xiuli Zhang, Yang Jin, Yong Gels Review Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulting in a short retention time and low drug bioavailability, which is a significant challenge for physicians, patients, and pharmacists. Nanogels, however, have the ability to encapsulate drugs within three-dimensional crosslinked polymeric networks and, through specific structural designs and distinct methods of preparation, achieve the controlled and sustained delivery of loaded drugs, increasing patient compliance and therapeutic efficiency. In addition, nanogels have higher drug-loading capacity and biocompatibility than other nanocarriers. In this review, the main focus is on the applications of nanogels for ocular diseases, whose preparations and stimuli-responsive behaviors are briefly described. The current comprehension of topical drug delivery will be improved by focusing on the advances of nanogels in typical ocular diseases, including glaucoma, cataracts, dry eye syndrome, and bacterial keratitis, as well as related drug-loaded contact lenses and natural active substances. MDPI 2023-04-02 /pmc/articles/PMC10137933/ /pubmed/37102904 http://dx.doi.org/10.3390/gels9040292 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wu, Yongkang
Tao, Qing
Xie, Jing
Lu, Lili
Xie, Xiuli
Zhang, Yang
Jin, Yong
Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_full Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_fullStr Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_full_unstemmed Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_short Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_sort advances in nanogels for topical drug delivery in ocular diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137933/
https://www.ncbi.nlm.nih.gov/pubmed/37102904
http://dx.doi.org/10.3390/gels9040292
work_keys_str_mv AT wuyongkang advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT taoqing advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT xiejing advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT lulili advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT xiexiuli advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT zhangyang advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT jinyong advancesinnanogelsfortopicaldrugdeliveryinoculardiseases